This case report corroborates the indication for patients affected by these rare tumors to be treated in higher- volume cancer centers to provide patients with more ex- perience and access to NGS diagnostic resources. Most importantly, it raises enthusiasm and hope toward precision medicine and tailored treatments for patients with PACC.
Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion
Gaule, Marina;Pesoni, Camilla;Zecchetto, Camilla;Casalino, Simona;Merz, Valeria;Contarelli, Serena;Pietrobono, Silvia;Melisi, Davide
2022-01-01
Abstract
This case report corroborates the indication for patients affected by these rare tumors to be treated in higher- volume cancer centers to provide patients with more ex- perience and access to NGS diagnostic resources. Most importantly, it raises enthusiasm and hope toward precision medicine and tailored treatments for patients with PACC.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
